This was the Attendees' Trusted Premier Platform Uniting the Microbiome Therapeutics Industry for Almost a Decade
The 9th Microbiome Movement Drug Development Summit was the industry-leading forum uniting the global microbial therapeutics industry across Live Biotherapeutics, FMT, Microbiome Targeting Small Molecules and more.
This was the attendees' crucial yearly touchpoint to collaborate and network with industry pioneers, as C-Level executives and investors gathered to close the translational gap, generate robust clinical data, navigate regulatory requirements and bring efficiency to community-wide manufacturing.
Watch: Highlights and Testimonials from the Microbiome Movement Drug Development Summit
Unmissable Agenda Highlights Included:
Explored how candidates were clinically progressing with Freya Biosciences, Maat Pharma & MRM Health, with MoA discoveries that lead to synergistic and accelerated pipeline development
Uncovered investment community perspectives on the latest innovative microbiome platform developments, to secure capital and scale attendees' biotech business with Conundrums Systems Biology, Seventure Partners, Fast-Track Initiative & Bill & Melinda Gates Foundation
Expertly navigated the field’s biggest bottlenecks through a program curated to address the latest novel R&D, strategic portfolio planning, clinical, translational and manufacturing intelligence
Dived into interactive sessions, with workshops, roundtables, panels, and poster sessions, which was led by the likes of the FDA and MHRA, to strengthen attendees' connections with field experts to tackle common challenges and accelerate future collaboration
Discovered the adoption of AI, ML, multi-omic, metabolomic and computational techniques revealing novel microbiome biomarkers to expedite R&D into viable drug candidates with Merck, Pfizer, UC San Diego
How Attendees Connected with the Microbiome Therapeutics Industry
Beyond scientific and strategic content, the 9th Microbiome Movement Drug Development Summit was designed to be the industry’s best partner for connection building in 2024.
As the leading minds of the field gathered under one roof alongside trailblazing start-ups, solution providers, regulatory and investor leadership, the program was built upon the backbone of supporting networking experiences to progress microbial therapeutics with invigorated investment.
